María Soledad Cruz Sáez

ORCID: 0000-0002-7905-7549
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Parathyroid Disorders and Treatments
  • Pancreatitis Pathology and Treatment
  • Health and Lifestyle Studies
  • Paraoxonase enzyme and polymorphisms
  • Eating Disorders and Behaviors
  • Developmental and Educational Neuropsychology
  • Protease and Inhibitor Mechanisms
  • Sports and Physical Education Studies
  • Iron Metabolism and Disorders
  • Peptidase Inhibition and Analysis
  • Educational theories and practices
  • Psychological Treatments and Disorders
  • Aging, Health, and Disability
  • Psychology Research and Bibliometrics
  • Thyroid Disorders and Treatments
  • IgG4-Related and Inflammatory Diseases
  • Blood Coagulation and Thrombosis Mechanisms
  • Higher Education Teaching and Evaluation
  • Research on Leishmaniasis Studies
  • Pharmacology and Obesity Treatment
  • Rheumatoid Arthritis Research and Therapies
  • Social Sciences and Policies
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Cardiovascular Conditions and Treatments

Hospital Italiano de Buenos Aires
2016-2025

Consejo Nacional de Investigaciones Científicas y Técnicas
2023

Instituto Universitario Hospital Italiano
2017-2018

University of the Basque Country
2002-2015

Universitat Autònoma de Barcelona
1998

Fundació Catalana per a la Recerca i la Innovació
1979

The European Coal and Steel Community (ECSC) prediction equations exemplify a significant effort carried out approximately 15 yrs ago to provide uniform standards for lung function testing, but this set of has not been properly validated as yet. present study evaluates the ECSC reference values four other sets equations, using spirometric data collected in 12,900 nonasthmatic subjects (43% lifetime nonsmokers 36% active smokers) aged 20-44 from Respiratory Health Survey (ECRHS). Standardized...

10.1183/09031936.98.11061354 article EN European Respiratory Journal 1998-06-01

Background Data on the epidemiology of amyloidosis are scarce worldwide, making it difficult to understand its true incidence and mortality. Aim The aim this study is estimate mortality rate systemic in people affiliated a Medical Care Program city Buenos Aires, Argentina. Methods This hospital-based prospective study. All affiliates over 17 years Hospital Italiano de incident cases deaths due from Institucional Amyloidosis Registry 1 January 2011 31 December 2022 were included. Incidence...

10.1136/bmjph-2024-001047 article EN cc-by-nc BMJ Public Health 2025-01-01

In patients with rheumatoid arthritis (RA), qualitative alterations of low and high-density lipoproteins (LDL HDL, respectively) might partially explain their increased cardiovascular risk. Tocilizumab has been associated an increase in lipids, including triglyceride (TG) cholesterol levels. The aim this study is to evaluate the effect tocilizumab on certain LDL HDL characteristics (oxidized levels, HDL-associated enzymes, chemical composition both total HDL3c subpopulation, capacity promote...

10.1007/s40744-021-00304-0 article EN cc-by-nc Rheumatology and Therapy 2021-04-02

La amiloidosis siempre ha representado un desafío diagnóstico. En el año 2020, Grupo de Estudio Amiloidosis (GEA), confeccionó la Guía Práctica Clínica para Diagnóstico Amiloidosis1-3. Nuevas líneas investigación se han desarrollado posteriormente. Esta revisión narrativa tiene como intención explorar estado del arte en diagnóstico amiloidosis. pacientes con recomienda tipificación proteína mediante espectrometría masa, técnica difícil ejecución por requerir microdisectores láser preparación...

10.51987/revhospitalbaires.v43i4.226 article ES cc-by-nc-sa Revista del Hospital Italiano de Buenos Aires 2024-01-08

Iron overload (IO) has been associated with glucose metabolism alterations and increased risk of cardiovascular disease (CVD). Primary IO is mutations in the HFE gene. To which extent gene metabolic contribute to presence atherogenic lipoprotein modifications primary remains undetermined. The present study aimed assess small, dense low-density (LDL) levels, chemical composition LDL high-density (HDL) particles, HDL functionality patients. Eighteen male patients 16 sex- age-matched controls...

10.1042/cs20140300 article EN Clinical Science 2014-12-03

Light chain (AL) amyloidosis is a form of systemic amyloidosis, causing organ dysfunction, mainly affecting the heart and kidney. Patient-tailored risk-adapted decision making critical in AL management. There limited real-world evidence data from Argentina Latin America regarding treatment approaches for amyloidosis. This retrospective cohort study aimed to describe patterns outcomes adult patients (>18 years) diagnosed with at Hospital Italiano Buenos Aires, Argentina, using...

10.1371/journal.pone.0274578 article EN cc-by PLoS ONE 2022-10-27

La amiloidosis AL es una enfermedad debida al depósito, en órganos y tejidos, de fibrillas formadas por depósito transtiretina poco frecuente se debe dicha proteína diversos aunque la afectación más cardíaca neurológica. Puede ser adquirida (antiguamente llamada “amiloidosis senil”) o hereditaria debido a mutaciones el gen que codifica para transtiretina.En 2020, Grupo Estudio Amiloidosis confeccionó guías práctica clínica tratamiento cardiomiopatía amiloidea transtiretina. Desde entonces...

10.51987/revhospitalbaires.v44i1.353 article ES cc-by-nc-sa Revista del Hospital Italiano de Buenos Aires 2024-03-29

La amiloidosis por depósito de transtiretina es una enfermedad infrecuente y se debe al fibrillas dicha proteína en diversos tejidos, aunque la afectación más frecuente cardíaca neurológica. Puede ser adquirida (antiguamente llamada “amiloidosis senil”) o, menos frecuentemente, hereditaria debido a mutaciones el gen que codifica para (TTR). Una manifestación habitual TTR mutada (de ahora adelante ATTRv) polineuropatía amiloidótica familiar. En Hospital Italiano Buenos Aires, desde año 2010...

10.51987/revhospitalbaires.v44i2.376 article ES cc-by-nc-sa Revista del Hospital Italiano de Buenos Aires 2024-06-28

Background Childhood obesity presents numerous comorbidities such as insulin resistance (IR) and dyslipidemia, could be associated with alterations in novel markers of cardiovascular (CV) risk like: (1) the activities enzymes lipoprotein phospholipase A 2 (Lp-PLA ) paraoxonase 1 (PON 1), (2) reverse cholesterol transport (RCT), which comprises cellular efflux (CCE), addition to lecithin:cholesterol acyltransferase (LCAT) cholesteryl ester transfer protein (CETP) activities, (3) high density...

10.1177/1973798x241304946 article EN other-oa Mediterranean Journal of Nutrition and Metabolism 2024-12-18
Coming Soon ...